Advisory Research Inc Ginkgo Bioworks Holdings, Inc. Transaction History

Advisory Research Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $29,373 - $150,486	40,237 Added 21.3%	229,158 $715,000
Q2 2022 Aug 17, 2022	BUY	$2.2 - $4.2 $199,577 - $381,011	90,717 Added 92.38%	188,921 $450,000
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $33,136 - $101,751	-11,709 Reduced 10.65%	98,204 $396,000
Q4 2021 Feb 11, 2022	BUY	$8.31 - $14.92 $302,841 - $543,729	36,443 Added 49.6%	109,913 $913,000
Q3 2021 Nov 12, 2021	BUY	$9.15 - $13.28 $672,250 - $975,681	73,470 New	73,470 $852,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $11.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.